SLC6A1 and epilepsy: These findings not only advance our understanding of the molecular mechanisms of disease, but pave the way for further clinical exploration and point toward enhanced treatment strategies for severe neurological disorders, such as for example, hGAT‐1‐related epilepsy and intellectual disability.